Case-control studies for identifying novel teratogens

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 157, Issue 3, 2011, Pages 201-208

  Werler, Martha M ^a   Louik, Carol ^b   Mitchell, Allen A ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Birth defects; Case control studies; Teratogens

Indexed keywords

ALCOHOL; CANNABIS; COCAINE;

ARTICLE; BIRTH DEFECT; CASE CONTROL STUDY; HUMAN; METHODOLOGY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PUBLIC HEALTH; REGISTER; RETROSPECTIVE STUDY; TERATOGENESIS;

CASE-CONTROL STUDIES; FEMALE; HUMANS; PREGNANCY; REGISTRIES; RESEARCH DESIGN; SELECTION BIAS; SMOKING; TERATOGENS;

EID: 79960554379     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30307     Document Type: Article

References (40)

1. AAAAI. 2011. American Academy of Allergy Asthma & Immunology: The Vaccines and Medications in Pregnancy Surveillance System (VAMPSS).
2. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A. 2007. Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79: 714-727.
3. Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA, National Birth Defects Prevention Study. 2011. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 204: 314.e1-314.e11.
4. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. 1996. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335: 1010-1015.
5. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. 2006. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354: 579-587.
6. Drews CD, Kraus JF, Greenland S. 1990. Recall bias in a case-control study of sudden infant death syndrome. Int J Epidemiol 19: 405-411.
7. Hensley Alford SM, Lappin RE, Peterson L, Johnson CC. 2009. Pregnancy associated smoking behavior and six year postpartum recall. Matern Child Health J 13: 865-872.
8. Hernández-Díaz S, Wu XF, Hayes C, Werler MM, Ashok TD, Badovinac R, Kelsey KT, Mitchell AA. 2005. Methylenetetrahydrofolate reductase polymorphisms and the risk of gestational hypertension. Epidemiology 16: 628-634.
9. Hernandez-Diaz S, Hauser R, Mitchell AA. 2010. Phthalates in drugs and male genital malformations. Pharmacoepidemiol Drug Saf 19: S221.
10. Jacobson SW, Jacobson JL, Sokol RJ, Martier SS, Ager JW, Kaplan MG. 1991. Maternal recall of alcohol, cocaine, and marijuana use during pregnancy. Neurotoxicol Teratol 13: 535-540.
11. Jurek AM, Greenland S, Maldonado G, Church TR. 2005. Proper interpretation of non-differential misclassification effects: Expectations vs observations. Int J Epidemiol 34: 680-687.
12. Klemetti A, Saxen L. 1967. Prospective versus retrospective approach in the search for environmental causes of malformations. Am J Public Health Nations Health 57: 2071-2075.
13. Lewis JD, Strom BL, Kimmel SE, Farrar J, Metz DC, Brensinger C, Nessel L, Localio AR. 2006. Predictors of recall of over-the-counter and prescription non-steroidal anti-inflammatory drug exposure. Pharmacoepidemiol Drug Saf 15: 39-45.
14. Louik C, Schatz M, Hernandez-Diaz S, Werler MM, Mitchell AA. 2010. Asthma in pregnancy and its pharmacologic treatment. Ann Allergy Asthma Immunol 105: 110-117.
15. Mackenzie SG, Lippman A. 1989. An investigation of report bias in a case-control study of pregnancy outcome. Am J Epidemiol 129: 65-75.
16. Mitchell AA. Studies of drug-induced birth defects. In: Strom B, editor. Pharmacoepidemiology. 4th edition. Chichester, England: Wiley and Sons.
17. Mitchell AA, Rosenberg L, Shapiro S, Slone D. 1981. Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA 245: 2311-2314.
18. Mitchell AA, Cottler LB, Shapiro S. 1986. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 123: 670-676.
19. Must A, Phillips SM, Naumova EN, Blum M, Harris S, Dawson-Hughes B, Rand WM. 2002. Recall of early menstrual history and menarcheal body size: After 30 years, how well do women remember? Am J Epidemiol 155: 672-679.
20. NBDPN. 2010. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2003-2007. Birth Defects Res A Clin Mol Teratol 88: 1062-1123.
21. Paganini-Hill A, Ross RK. 1982. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 116: 114-122.
22. Peller AJ, Westgate MN, Holmes LB. 2004. Trends in congenital malformations, 1974-1999: Effect of prenatal diagnosis and elective termination. Obstet Gynecol 104: 957-964.
23. Rasmussen SA, Lammer EJ, Shaw GM, Finnell RH, McGehee RE Jr, Gallagher M, Romitti PA, Murray JC. 2002. Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology 66: 177-184.
24. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67: 193-201.
25. Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. 1979. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 109: 433-439.
26. Sanderson M, Williams MA, White E, Daling JR, Holt VL, Malone KE, Self SG, Moore DE. 1998. Validity and reliability of subject and mother reporting of perinatal factors. Am J Epidemiol 147: 136-140.
27. Schatz M, Chambers CD, Jones KL, Louik C, Mitchell AA. 2011. Safety of influenza immunizations and treatment during pregnancy: The Vaccines and Medications in Pregnancy Surveillance System. Am J Obstet Gynecol 204 (6 Suppl 1): S64-S68.
28. Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, Willett WC, Buka SL. 1999. Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology 10: 774-777.
29. Tourangeau R, Rips LJ, Rasinski K. 2000. The role of memory in survey responding. The psychology of survey response. Cambridge, UK: Cambridge University Press. pp 62-99.
30. Waller DK, Mills JL, Simpson JL, Cunningham GC, Conley MR, Lassman MR, Rhoads GG. 1994. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 170: 541-548.
31. Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, Gallaway MS, Correa A. 2007. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 161: 745-750.
32. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. 2003. Maternal obesity and risk for birth defects. Pediatrics 111: 1152-1158.
33. Werler MM, Mitchell AA, Shapiro S. 1992. First trimester maternal medication use in relation to gastroschisis. Teratology 45: 361-367.
34. Werler MM, Louik C, Shapiro S, Mitchell AA. 1996. Prepregnant weight in relation to risk of neural tube defects. JAMA 275: 1089-1092.
35. Werler MM, Hayes C, Louik C, Shapiro S, Mitchell AA. 1999. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 150: 675-682.
36. Werler MM, Sheehan JE, Mitchell AA. 2002. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 155: 26-31.
37. Yawn BP, Suman VJ, Jacobsen SJ. 1998. Maternal recall of distant pregnancy events. J Clin Epidemiol 51: 399-405.
38. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. 2001. The National Birth Defects Prevention Study. Public Health Rep 116: 32-40.
39. Zagon IS, Wu Y, McLaughlin PJ. 1999. Opioid growth factor and organ development in rat and human embryos. Brain Res 839: 313-322.
40. Zierler S, Rothman KJ. 1985. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 313: 347-352.